Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis

الملخص EN

Etanercept is a monoclonal antibody targeted against Tumour Necrosis Factor-alpha (TNF-a) which is an effective treatment for rheumatoid arthritis and is in cases where conventional disease modifying agents such as methotrexate have failed.

Neurological complications of treatment have been documented.

We describe a case of transverse myelitis occurring in a 48 year-old lady with RA since 1994 who had been receiving etanercept for four years.